The molecular genetics of follicular lymphoma
Status of the ZUMA-3 trial of CAR T-cell product KTE-C19 for R/R ALL
Are there promising treatment options for multiple myeloma on the horizon?
Impact of somatic gene mutations on response to lenalidomide in MDS patients
What we are learning about CLL treatments and the microenvironment